Related Experiment Video
Updated: Sep 9, 2025

10:49
Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
Published on: August 21, 2021
4.6K
[Dexamethasone - Risk Factor for Wound Healing Disorder and Hyperglycaemia?]
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|September 4, 2025
Summary
A single 8 mg dose of dexamethasone during surgery effectively reduces postoperative nausea, pain, and hospital stays. This steroid treatment is safe for well-controlled diabetes patients, with only minor, clinically insignificant blood sugar increases.
Area of Science:
- Anesthesiology
- Pharmacology
- Surgical Care
Background:
- Postoperative nausea and vomiting (PONV) are common complications.
- Pain management and reduced hospital stays are key goals in surgical recovery.
- Wound healing and glycemic control are critical considerations for surgical patients.
Purpose of the Study:
- To evaluate the efficacy of a single 8 mg dexamethasone dose in reducing postoperative complications.
- To assess the safety of perioperative dexamethasone in patients with well-controlled diabetes mellitus.
- To determine the impact of dexamethasone on wound healing and blood glucose levels.
Main Methods:
- Prospective study design.
- Single administration of 8 mg dexamethasone during surgery.
- Monitoring of postoperative nausea, pain scores, hospital duration, wound healing, and blood glucose levels.
Main Results:
- Dexamethasone significantly reduced postoperative nausea, pain, and length of hospitalization.
- No increased risk of wound healing disorders was observed.
- Patients with well-controlled diabetes showed a slight, clinically insignificant increase in blood sugar levels.
Conclusions:
- Single-dose perioperative dexamethasone is a safe and effective option for managing postoperative outcomes.
- This intervention improves patient recovery without compromising wound integrity.
- Dexamethasone can be safely used in diabetic patients undergoing surgery, with careful glycemic monitoring.
Related Concept Videos
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications
684
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
684
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Insulin: Dosing Regimen and Adverse Effects
252
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
252
Adrenal Gland Disorders
1.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.8K

